Prof. Harry Holthöfer, MD, PhD,graduated from the University of Helsinki, Finland andspecialized in clinical
microbiology/immunology. His hospital-based positions have included those of internal medicine, pulmology, pediatrics and occupational health.
The research of Prof Holthöfer has focused on the biology of the kidney glomerular filtration barrier, particularly in congenital
nephrotic syndrome as well as kidney complications of diabetes. For that, various approaches of molecular and cell biology, biochemistry combined with in vitro and in vivo analytical platforms
have revealed new integral molecules constituting the functional kidney filtration barrier. The present main research line includes development of new methods for comprehensive understanding of
urinary vesicles (including exosomes), their functions and value as new source for biomarkers.
He became Professor and Director of the Technomedicum Research Centre from 2001-2006 in Finland and subsequently moved to
Ireland to take up the Professorship and Chair of Bioanalytical Sciences at Dublin City University and to become Director of the Center for Bioanalytical Sciences in September 2006. After a
fellowship at Freiburg Institute for Advanced Studies (FRIAS), Albert-Ludwigs University Freiburg, he joined the team at University Clinic Hamburg-Eppendorf as Visiting Professor to fully focus
on biology of urinary extracellular vesicles in diabetes and diabetic kidney disease.